Shilpa Medicare Limited — Important, 24-05-2025: General Updates

Shilpa Medicare reshuffles leadership at Shilpa Pharma Lifesciences, with Mr. Keshav Bhutada taking over as CEO from Mr. Santosh Mahil. Mr. Madhav Bhutada will head biologics, focusing on biosimilars and microbial fermentation. This move aims to strengthen management, enhance focus on key verticals like API expansion, oncology, peptides, and CDMO, and drive sustainable growth and capital efficiency across the group.